LV12342B - PROGESTERON FOR REDUCTION OR REDUCTION OF EXTRACTION - Google Patents

PROGESTERON FOR REDUCTION OR REDUCTION OF EXTRACTION Download PDF

Info

Publication number
LV12342B
LV12342B LVP-99-88A LV990088A LV12342B LV 12342 B LV12342 B LV 12342B LV 990088 A LV990088 A LV 990088A LV 12342 B LV12342 B LV 12342B
Authority
LV
Latvia
Prior art keywords
ischemia
progesterone
pharmaceutical preparation
myocardial ischemia
preparation according
Prior art date
Application number
LVP-99-88A
Other languages
English (en)
Latvian (lv)
Other versions
LV12342A (lv
Inventor
Howard L. Levine
William J. Bologna
Original Assignee
Columbia Laboratories (Bermuda) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24987712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV12342(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Laboratories (Bermuda) Limited filed Critical Columbia Laboratories (Bermuda) Limited
Publication of LV12342A publication Critical patent/LV12342A/xx
Publication of LV12342B publication Critical patent/LV12342B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-99-88A 1996-11-04 1999-05-28 PROGESTERON FOR REDUCTION OR REDUCTION OF EXTRACTION LV12342B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/743,153 US5985861A (en) 1996-11-04 1996-11-04 Progesterone for treating or reducing ischemia
PCT/US1997/020923 WO1998019681A1 (en) 1996-11-04 1997-11-04 Progesterone for treating or reducing ischemia

Publications (2)

Publication Number Publication Date
LV12342A LV12342A (lv) 1999-09-20
LV12342B true LV12342B (en) 2000-01-20

Family

ID=24987712

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-88A LV12342B (en) 1996-11-04 1999-05-28 PROGESTERON FOR REDUCTION OR REDUCTION OF EXTRACTION

Country Status (27)

Country Link
US (2) US5985861A (es)
EP (1) EP0956023B1 (es)
KR (1) KR100434623B1 (es)
CN (1) CN100341512C (es)
AR (1) AR009407A1 (es)
AT (1) ATE321558T1 (es)
AU (1) AU715740C (es)
BR (1) BR9710918A (es)
CA (1) CA2270565C (es)
DE (1) DE69735598T2 (es)
DK (1) DK0956023T3 (es)
ES (1) ES2262196T3 (es)
GE (1) GEP20022630B (es)
HK (1) HK1020534A1 (es)
HU (1) HUP9904045A3 (es)
IL (1) IL127455A (es)
LV (1) LV12342B (es)
MA (1) MA24391A1 (es)
MY (1) MY121627A (es)
NO (1) NO324278B1 (es)
NZ (1) NZ335306A (es)
PE (1) PE9899A1 (es)
PT (1) PT956023E (es)
RO (1) RO120607B1 (es)
UA (1) UA66772C2 (es)
WO (1) WO1998019681A1 (es)
ZA (1) ZA979862B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
US6602487B1 (en) 1997-02-26 2003-08-05 Dimera Incorporated Methods and tests for producing and for inhibiting coronary artery vasospasms
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
GB0107383D0 (en) * 2001-03-23 2001-05-16 Univ Edinburgh Lipid profile modulation
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US7572780B2 (en) * 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
WO2004096151A2 (en) * 2003-04-29 2004-11-11 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
DE102005027004B4 (de) * 2005-06-10 2020-03-19 Continental Automotive Gmbh Scheibenwaschvorrichtung
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CA2713943C (en) * 2008-02-04 2018-10-23 Teva Women's Health, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2951284A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
JP2019513709A (ja) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． ステロイドホルモン薬学的組成物
US11787835B2 (en) 2018-09-07 2023-10-17 Trustees Of Dartmouth College C19 scaffolds and steroids and methods of use and manufacture thereof
US11512107B2 (en) 2018-09-07 2022-11-29 Trustees Of Dartmouth College Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1124906A1 (ru) * 1982-05-25 1984-11-23 Ивановский государственный медицинский институт им.А.С.Бубнова Способ коррекции ишемических повреждений консервированной донорской почки
US4615697A (en) * 1983-11-14 1986-10-07 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof

Also Published As

Publication number Publication date
CA2270565C (en) 2007-02-20
US6054447A (en) 2000-04-25
KR100434623B1 (ko) 2004-06-05
AU5180198A (en) 1998-05-29
PT956023E (pt) 2006-08-31
HK1020534A1 (en) 2000-05-12
NO324278B1 (no) 2007-09-17
PE9899A1 (es) 1999-02-08
AR009407A1 (es) 2000-04-12
DK0956023T3 (da) 2006-08-07
UA66772C2 (uk) 2004-06-15
DE69735598D1 (de) 2006-05-18
GEP20022630B (en) 2002-02-25
CN100341512C (zh) 2007-10-10
NZ335306A (en) 2000-12-22
AU715740B2 (en) 2000-02-10
RO120607B1 (ro) 2006-05-30
MA24391A1 (fr) 1998-07-01
LV12342A (lv) 1999-09-20
KR20000053056A (ko) 2000-08-25
BR9710918A (pt) 2000-01-11
ZA979862B (en) 1998-05-25
CA2270565A1 (en) 1998-05-14
MY121627A (en) 2006-02-28
EP0956023A1 (en) 1999-11-17
NO992140D0 (no) 1999-05-03
CN1235549A (zh) 1999-11-17
US5985861A (en) 1999-11-16
WO1998019681A1 (en) 1998-05-14
NO992140L (no) 1999-05-04
IL127455A (en) 2005-03-20
HUP9904045A2 (hu) 2000-04-28
DE69735598T2 (de) 2006-12-28
ATE321558T1 (de) 2006-04-15
HUP9904045A3 (en) 2000-11-28
ES2262196T3 (es) 2006-11-16
IL127455A0 (en) 1999-10-28
AU715740C (en) 2004-04-29
EP0956023B1 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
US5985861A (en) Progesterone for treating or reducing ischemia
JP3211892B2 (ja) 肛門疾患を治療する窒素酸化物供与体及び方法
Nilsson et al. Treatment of menorrhagia
US6306914B1 (en) Progestin therapy for maintaining amenorrhea
US7749987B2 (en) Contraception method
US20040110732A1 (en) Pharmaceutical composition for transdermal or transmucosal administration comprising at least one progestin and/or at least one oestrogen, process for preparing it and uses thereof
US20030064975A1 (en) Hormone composition
WO2000037071A1 (en) Topical treatment of skin disease
KR100450649B1 (ko) 호르몬약물및에스트로겐결핍을치유하기위한그의용도
Zoma et al. Effects of combined use of sildenafil citrate (Viagra) and 17β-estradiol on ovine coronary and uterine hemodynamics
JPS6227A (ja) 皮膚科ならびに眼科用の外傷、潰瘍治療用クリーム剤
DE60036723T2 (de) Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
MXPA99004130A (es) Progesterona para el tratamiento o la reduccion de isquemia
JPS63101326A (ja) 子宮でのプロスタグランジン合成抑制剤
Arnt et al. Low-dose combination oral contraceptives: a controlled clinical study of three different norgestrel-ethinyl estradiol ratios
JP2002503215A (ja) 虚血を治療又は抑制するためのプロゲステロン
Seeger et al. Additive antioxidative effect of hormone replacement therapy
UA79421C2 (en) Progestin therapy with regular menstrual bleeding
MXPA96000386A (es) Composicion donadora de oxido nitrico y metodo para el tratamiento de desordenes anales
JPS597682B2 (ja) 軟膏基剤